Characteristic | GAVE n (%) or median (IQR 25th-75th) | p-value |
---|---|---|
Demographics | ||
 Age at GAVE diagnosis, years | 55.94 (47.25-66.46) |  |
 SSc durationa at GAVE diagnosis, years | 4.00 (0.84-12.42) |  |
 Limited disease subtype | 5.25 (0.50-16.08) |  |
 Diffuse disease subtype | 3.08 (1.25-9.59) | 0.003 |
 Female | 188 (87.0%) |  |
 Diffuse disease subtype | 72 (35.3%) |  |
 Caucasian | 183 (91.5%) |  |
 Follow-up from GAVE diagnosis, years | 6.88 (2.99-11.16) |  |
Serological markers at GAVE diagnosis | ||
 inflammatory markers |  |  |
 CRP | 4.00 (2.75-7.50) |  |
 ESR | 17.50 (9.00-27.00) |  |
 platelets | 298.00 (256.00-351.00) |  |
 albumin | 37.00 (35.00-40.00) |  |
 Anaemia at GAVE diagnosis | 19 (31.7%) |  |
 Drop in Hb of 10g pre-GAVE diagnosis | 91 (53.8%) |  |
 Drop in Hb of 10g post GAVE diagnosis | 75 (37.5%) |  |
 Increase in MRSS in preceding 12months of dx | 15 (24.2%) |  |
Clinical markers at GAVE diagnosis | ||
 Increasing breathlessness | 46 (23.5%) |  |
 Decrease in DLCO | 71 (42.3%) |  |